X

Xponance Portfolio holdings

AUM $16.3B Turnover 12.69%
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$9.78B
AUM Growth
+$239M
Cap. Flow
-$199M
Cap. Flow %
-2.04%
Top 10 Hldgs %
39.84%
Holding
1,386
New
76
Increased
471
Reduced
763
Closed
70
Avg Time Held
3 years
Top 10 Avg Time Held
3 years
Top 20 Avg Time Held
2.6 years

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$24.4M
2
ORCL icon
Oracle
ORCL
+$10.8M
3
AMZN icon
Amazon
AMZN
+$10.3M
4
COST icon
Costco
COST
+$7.38M
5
XOM icon
ExxonMobil
XOM
+$6.78M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$32.3M
2
ACN icon
Accenture
ACN
+$18.1M
3
ABBV icon
AbbVie
ABBV
+$14.4M
4
TMO icon
Thermo Fisher Scientific
TMO
+$13.3M
5
CAT icon
Caterpillar
CAT
+$10.7M

Sector Composition

Rank Sector Weight
1 Technology 37.1%
2 Consumer Discretionary 11.12%
3 Healthcare 10.76%
4 Financials 10.45%
5 Communication Services 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
AIT icon
676
Applied Industrial Technologies
AIT
$12.3B
$1.01M 0.01%
5,207
-329
-6% -$62.7K
2022 Q2
8 quarters
FLR icon
677
Fluor
FLR
$6.37B
$1.01M 0.01%
23,097
+265
+1% +$11K
2020 Q2
16 quarters
KBR icon
678
KBR
KBR
$4.44B
$1M 0.01%
15,607
-4,717
-23% -$305K
2020 Q2
16 quarters
HQY icon
679
HealthEquity
HQY
$7.43B
$1M 0.01%
11,601
-709
-6% -$57.3K
2020 Q2
16 quarters
ATR icon
680
AptarGroup
ATR
$7.65B
$999K 0.01%
7,098
-751
-10% -$109K
2020 Q2
16 quarters
CVNA icon
681
Carvana
CVNA
$41.7B
$995K 0.01%
38,655
+6,885
+22% +$139K
2023 Q3
3 quarters
TWLO icon
682
Twilio
TWLO
$41.6B
$991K 0.01%
17,440
+561
+3% +$33.1K
2020 Q2
16 quarters
OHI icon
683
Omega Healthcare
OHI
$13.7B
$984K 0.01%
28,732
-4,589
-14% -$145K
2020 Q2
16 quarters
ARMK icon
684
Aramark
ARMK
$14.4B
$980K 0.01%
28,798
-2,867
-9% -$93K
2022 Q4
6 quarters
RRX icon
685
Regal Rexnord
RRX
$10.5B
$966K 0.01%
7,143
-748
-9% -$116K
2020 Q2
16 quarters
BEN icon
686
Franklin Templeton
BEN
$15.5B
$959K 0.01%
42,904
-3,272
-7% -$78.8K
2020 Q2
16 quarters
MKSI icon
687
MKS Inc
MKSI
$15.9B
$956K 0.01%
7,319
-337
-4% -$42.5K
2020 Q2
16 quarters
GWRE icon
688
Guidewire Software
GWRE
$13.5B
$953K 0.01%
6,908
+3,066
+80% +$369K
2023 Q1
5 quarters
SF icon
689
Stifel
SF
$10.2B
$934K 0.01%
16,643
-1,908
-10% -$101K
2020 Q2
16 quarters
PCOR icon
690
Procore
PCOR
$8.5B
$933K 0.01%
14,067
+3,545
+34% +$246K
2021 Q4
10 quarters
CMC icon
691
Commercial Metals
CMC
$7.22B
$932K 0.01%
16,957
-1,150
-6% -$63.4K
2020 Q2
16 quarters
FHN icon
692
First Horizon
FHN
$10.7B
$930K 0.01%
58,986
-7,870
-12% -$119K
2020 Q2
16 quarters
HALO icon
693
Halozyme
HALO
$13.3B
$930K 0.01%
17,762
-1,101
-6% -$48.3K
2020 Q4
14 quarters
DCI icon
694
Donaldson
DCI
$10.1B
$927K 0.01%
12,960
-5,843
-31% -$429K
2020 Q2
16 quarters
UFPI icon
695
UFP Industries
UFPI
$4.18B
$926K 0.01%
8,272
-510
-6% -$59.3K
2021 Q4
10 quarters
EHC icon
696
Encompass Health
EHC
$12.5B
$923K 0.01%
10,759
-1,761
-14% -$148K
2020 Q2
16 quarters
LPX icon
697
Louisiana-Pacific
LPX
$4.65B
$922K 0.01%
11,194
+3,561
+47% +$297K
2020 Q2
16 quarters
CAVA icon
698
CAVA Group
CAVA
$6.03B
$913K 0.01%
9,846
+4,803
+95% +$371K
2024 Q1
1 quarter
ITCI icon
699
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$913K 0.01%
13,329
+7,671
+136% +$532K
2022 Q1
9 quarters
EXAS icon
700
DELISTED
Exact Sciences
EXAS
$912K 0.01%
21,576
+799
+4% +$44K
2020 Q2
16 quarters
26 27
28
29 30

Similar funds

PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
BS
Banco Santander Madrid, Spain $16.1B AUM 35.02% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $16.1B AUM 40.83% 1-Year Est. Return
NMO
Newlands Management Operations Dallas, Texas $16.6B AUM 3.91% 1-Year Est. Return
PAS
Park Avenue Securities New York $16B AUM 26.77% 1-Year Est. Return

Xponance's Q2 2024 Portfolio in Review

As of Q2 2024, Xponance held 1,386 positions worth $9.78B, up 2.5% from $9.54B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Xponance's Q2 2024 filing shows 76 new, 471 increased, 763 reduced and 70 closed positions. Its largest new stake was GE Vernova: 36,466 shares worth $6.25M. The largest sale was UnitedHealth, an estimated $32.3M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Xponance's largest Q2 2024 buy was GE Vernova: 36,466 shares worth $6.25M.
  • Xponance added most to Merck in Q2 2024, an estimated $24.4M increase.
  • Xponance's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $32.3M.
  • Xponance fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $8.15M.
  • Xponance's ten largest holdings make up 40% of its $9.78B portfolio in Q2 2024.
  • Xponance opened 76 new positions and closed 70 in Q2 2024.
  • Xponance's portfolio value rose 2.5% quarter-over-quarter to $9.78B.

Based on Xponance's 13F filing for Q2 2024, filed 14 Aug 2024.